{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-080764","form_type":"8-K","ticker":"BCYC","cik":"0001761612","company_name":"BICYCLE THERAPEUTICS PLC","filed_at":"2023-07-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.150213+00:00","generated_at":"2026-06-13T08:50:09.180586+00:00","sec_items":["1.01","2.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bicycle Therapeutics raises ~$187M net in public offering of 9.4M ADSs at $21.25/sh","bullets":["Public offering of 9,411,766 ADSs (or non-voting ordinary shares) at $21.25 per share; net proceeds ~$187.3M.","Underwriters granted 30-day option to purchase up to 1,411,764 additional ADSs.","Preliminary cash and cash equivalents of ~$340.4M as of June 30, 2023 (unaudited).","Offering expected to close July 17, 2023; 60-day lock-up for directors, officers and company."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-080764","json":"https://secwatch.observer/filing/0001104659-23-080764.json","markdown":"https://secwatch.observer/filing/0001104659-23-080764.md","text":"https://secwatch.observer/filing/0001104659-23-080764.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923080764/0001104659-23-080764-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923080764/tm2321220d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T08:50:09.180586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ffd046ce3b1cfb4b3fbc19b6991e2a03e48e53a6","claim":"BICYCLE THERAPEUTICS PLC entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (Representatives) valued at approximately $187.3 million (effective 2023-07-12).","evidence_excerpt":"On July 12, 2023, Bicycle Therapeutics plc (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (the “ Representatives ”), as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), pursuant to which the Company agreed to issue and sell 9,411,766 American Depositary Shares (“ ADSs ”), each representing one of the Company’s ordinary shares, nominal value £0.01 per share, and, in lieu of ADSs to investors that so choose, non-voting ordinary shares, nominal value £0.01 per share (“ Non-Voting Ordinary Shares ”), each at a public offering price of $21.25 per share (the “ Offering ”). The net proceeds to the Company from the Offering are expected to be approximately $187.3 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1761612/000110465923080764/0001104659-23-080764-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Goldman Sachs & Co. LLC, Jefferies LLC and SVB Securities LLC (Representatives)"},{"label":"Value","value":"approximately $187.3 million"},{"label":"Effective","value":"2023-07-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}